A Phase II Study of Maintenance Therapy With Temsirolimus in Androgen-Independent Prostate Cancer After First Line Chemotherapy With Docetaxel

Trial Profile

A Phase II Study of Maintenance Therapy With Temsirolimus in Androgen-Independent Prostate Cancer After First Line Chemotherapy With Docetaxel

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2016

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 21 Jun 2010 New trial record
    • 04 Jun 2010 Details of trial design presented at the the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO-2010).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top